Rapid Micro Biosystems (RPID) Return on Capital Employed (2021 - 2026)
Rapid Micro Biosystems (RPID) reported Return on Capital Employed of 100.19% for Q1 2026, down 3860.0% on a YoY basis from 2.66% in Q1 2025, and down 29.26% sequentially from 77.51% in Q4 2025.
Rapid Micro Biosystems (RPID) Return on Capital Employed (2021 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 6 years of Return on Capital Employed data on file, last reported at 100.19% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 3860.0% year-over-year to 100.19%; the trailing twelve-month figure through Mar 2026 stood at 100.19% (down 3860.0% YoY), and the FY2025 full-year result was 69.67%, down 2132.0% from the prior year.
- Return on Capital Employed fell to 100.19% in Q1 2026, from 77.51% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 23.8% in Q1 2022 to a low of 100.19% in Q1 2026.
- A 5-year average of 51.71% and a median of 46.64% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed tumbled 688 bps in 2022 and plunged 3860 bps in 2026, its largest moves.
- Tracing RPID's Return on Capital Employed over 5 years: stood at 35.67% in 2022, then retreated by 24 bps to 44.25% in 2023, then tumbled by 34 bps to 59.12% in 2024, then tumbled by 31 bps to 77.51% in 2025, then slipped by 29 bps to 100.19% in 2026.
- Business Quant data shows RPID's Return on Capital Employed at 100.19% in Q1 2026, 77.51% in Q4 2025, and 71.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.84 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.95 Bn | 99.73 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.42 Bn | 66.97 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 9.30% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 24.24% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 8.38% |
| 10 | Rapid Micro Biosystems | 89.05 Mn | 79.62 Mn | 371,000.00 | -100.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.19% |
| Dec 31, 2025 | -77.51% |
| Sep 30, 2025 | -71.57% |
| Jun 30, 2025 | -71.88% |
| Mar 31, 2025 | -61.59% |
| Dec 31, 2024 | -59.12% |
| Sep 30, 2024 | -54.30% |
| Jun 30, 2024 | -51.31% |
| Mar 31, 2024 | -46.64% |
| Dec 31, 2023 | -44.25% |
| Sep 30, 2023 | -44.04% |
| Jun 30, 2023 | -41.96% |
| Mar 31, 2023 | -37.49% |
| Dec 31, 2022 | -35.67% |
| Sep 30, 2022 | -31.22% |
| Jun 30, 2022 | -26.50% |
| Mar 31, 2022 | -23.80% |
| Dec 31, 2021 | -20.57% |
| Sep 30, 2021 | -24.35% |